Pasar al contenido principal

REGULADORES DE LA CROMATINA: DESDE EL MECANISMOS MOLECULARES A LAIDENTIFICACION DE DIANAS PARA EL TRATAMIENTO DE ENFERMEDADES HUMANAS

PID2022-142679NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The interferon γ pathway enhances pluripotency and X-chromosome reactivation in iPSC reprogramming

  • Barrero, Mercedes|||0000-0001-7178-1885
  • Lazarenkov, Aleksey|||0000-0003-0652-8116
  • Blanco, Enrique|||0000-0001-6261-7370
  • Palma, Luis G.|||0000-0001-5170-0507
  • López-Rubio, Anna V.|||0000-0001-8664-6205
  • Bauer, Moritz|||0000-0002-5937-8169
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Di Croce, Luciano|||0000-0003-3488-6228
  • Sardina, José Luis|||0000-0002-8493-3937
  • Payer, Bernhard|||0000-0002-4694-2082
Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) requires activation of the pluripotency network and resetting of the epigenome by erasing the epigenetic memory of the somatic state. In female mouse cells, a critical epigenetic reprogramming step is the reactivation of the inactive X chromosome. Despite its importance, a systematic understanding of the regulatory networks linking pluripotency and X-reactivation is missing. Here, we reveal important pathways for pluripotency acquisition and X-reactivation using a genome-wide CRISPR screen during neural precursor to iPSC reprogramming. In particular, we discover that activation of the interferon γ (IFNγ) pathway early during reprogramming accelerates pluripotency acquisition and X-reactivation. IFNγ stimulates STAT3 signaling and the pluripotency network and leads to enhanced TET-mediated DNA demethylation, which consequently boosts X-reactivation. We therefore gain a mechanistic understanding of the role of IFNγ in reprogramming and X-reactivation and provide a comprehensive resource of the molecular networks involved in these processes.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The interferon γ pathway enhances pluripotency and X-chromosome reactivation in iPSC reprogramming

  • Barrero Asencio, Mercedes
  • Lazarenkov, Aleksey
  • Blanco, Enrique
  • Palma, Luis G.
  • López Rubio, Anna V.
  • Bauer, Moritz, 1987-
  • Bigas Salvans, Anna
  • Di Croce, Luciano
  • Sardina, Jose Luis
  • Payer, Bernhard
Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) requires activation of the pluripotency network and resetting of the epigenome by erasing the epigenetic memory of the somatic state. In female mouse cells, a critical epigenetic reprogramming step is the reactivation of the inactive X chromosome. Despite its importance, a systematic understanding of the regulatory networks linking pluripotency and X-reactivation is missing. Here, we reveal important pathways for pluripotency acquisition and X-reactivation using a genome-wide CRISPR screen during neural precursor to iPSC reprogramming. In particular, we discover that activation of the interferon γ (IFNγ) pathway early during reprogramming accelerates pluripotency acquisition and X-reactivation. IFNγ stimulates STAT3 signaling and the pluripotency network and leads to enhanced TET-mediated DNA demethylation, which consequently boosts X-reactivation. We therefore gain a mechanistic understanding of the role of IFNγ in reprogramming and X-reactivation and provide a comprehensive resource of the molecular networks involved in these processes., This work was supported by Agencia Estatal de Investigación (AEI) of the Spanish Ministry of Science and Innovation (MCIN) and Fondo Europeo de Desarrollo Regional (FEDER) of the European Union grant BFU2017-88407-P (B.P.); AEI of MCIN grant EUR2019-103817/AEI/10.13039/501100011033 (B.P.); grant PID2021-123383NB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE (B.P.); AEI of MCIN grant PID2019-111243RA-I00 (J.L.S.); AEI of MCIN grant PID2022-142679NB-I00 (L.D.C.); AXA Research Fund (B.P.); Agencia de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) 2017 grant SGR 346 (B.P.); AGAUR 2021 grant SGR 01222 (B.P.); Instituto de Salud Carlos III grant CP19/00176 (J.L.S.); Worldwide Cancer Research 20-0269 (J.L.S.); Ramón Areces Foundation (Doctoral Thesis in Life Sciences Fellowship) (M. Barrero); and La Caixa International PhD Fellowship Program (M. Bauer).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

KDM6 demethylases contribute to EWSR1::FLI1-driven oncogenic reprogramming in Ewing sarcoma

  • Figuerola-Bou, Elisabet
  • Ríos-Astorch, Carla
  • Blanco, Enrique
  • Sánchez-Jiménez, María
  • Táboas, Pablo
  • Fernández, Guerau
  • Gómez-González, Soledad
  • Muñoz, Oscar
  • Castellano-Escuder, Pol
  • Perez-Jaume, Sara
  • Garcia, Marta
  • Prada, Estela
  • Mateo-Lozano, Silvia
  • Riggi, Nicolo
  • Avgustinova, Alexandra
  • Lavarino, Cinzia
  • Di Croce, Luciano
  • Sánchez-Molina, Sara
  • Mora, Jaume
Ewing sarcoma is a highly aggressive tumor arising in bones and soft tissues, driven by the fusion oncoprotein EWSR1::FLI1. This aberrant transcription factor binds to GGAA microsatellites, causing epigenetic reprogramming through the formation of active neoenhancers in a permissive cellular context. Inhibition of the oncogene remains challenging, and current efforts seek to exploit emergent epigenetic treatments targeting EWSR1::FLI1 cofactors. In Ewing sarcoma, neoenhancers are characterized by strong enrichment of the active H3K27ac mark and a concomitant lack of the repressive H3K27me3 mark. These regions are typically decorated with high levels of H3K27me3 prior to EWSR1::FLI1 activation. In this study, upon expression of EWSR1::FLI1 in human pediatric mesenchymal stem cells, considered the putative cell of origin of Ewing sarcoma, we unraveled the genome-wide redistribution of H3K27me3. Stemming from these results, we elucidated the contribution of the H3K27me3 demethylases KDM6A/UTX and KDM6B/JMJD3 in the transcriptional activity of EWSR1::FLI1-induced enhancers. KDM6A had a demethylase-independent role in recruiting BRG1 at EWSR1::FLI1-primed enhancers containing single GGAA motifs, which was critical for Ewing sarcoma tumor growth. Conversely, KDM6B demethylated H3K27me3 at specific EWSR1::FLI1-active enhancers, colocalizing with BRG1 at GGAA repeats. Loss of KDM6B impaired the growth of Ewing sarcoma tumor xenografts. These results highlight KDM6 demethylases as EWSR1::FLI1 functional partners with potential as targets for treating Ewing sarcoma., Our studies were supported by grants from AGAUR; the Spanish government through the Instituto de Salud Carlos III (PI16/00245 to J. Mora); the Ministry of Economy, Industry and Competitiveness (PID2022-142679NB-I00 to L. Di Croce); the Fundació La Caixa Health Research Grant (CI24-10473 to L. Di Croce); and Worldwide Cancer Research (2025_038 to L. Di Croce). We thank Dr. Marian Martínez-Balbás (Instituto de Biología Molecular de Barcelona, Consejo Superior de Investigaciones Científicas) for the critical reading of the manuscript. We also thank Dr. Mariona Suñol and Sandra Rincón (Hospital Sant Joan de Déu). We are grateful to the Band of Parents at Hospital Sant Joan de Déu for supporting the overall research activities of the Pediatric Cancer Group (Institut de Recerca Sant Joan de Déu and Pediatric Cancer Center Barcelona).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

KDM6 demethylases contribute to EWSR1::FLI1-driven oncogenic reprogramming in Ewing sarcoma

  • Figuerola-Bou, Elisabet
  • Ríos-Astorch, Carla
  • Blanco, Enrique
  • Sánchez-Jiménez, María
  • Táboas, Pablo
  • Fernández, Guerau
  • Gómez-González, Soledad
  • Muñoz, Oscar
  • Castellano-Escuder, Pol
  • Perez-Jaume, Sara
  • Garcia, Marta
  • Prada, Estela
  • Mateo-Lozano, Silvia
  • Riggi, Nicolo
  • Avgustinova, Alexandra
  • Lavarino, Cinzia
  • Di Croce, Luciano
  • Sánchez-Molina, Sara
  • Mora, Jaume
Ewing sarcoma is a highly aggressive tumor arising in bones and soft tissues, driven by the fusion oncoprotein EWSR1::FLI1. This aberrant transcription factor binds to GGAA microsatellites, causing epigenetic reprogramming through the formation of active neoenhancers in a permissive cellular context. Inhibition of the oncogene remains challenging, and current efforts seek to exploit emergent epigenetic treatments targeting EWSR1::FLI1 cofactors. In Ewing sarcoma, neoenhancers are characterized by strong enrichment of the active H3K27ac mark and a concomitant lack of the repressive H3K27me3 mark. These regions are typically decorated with high levels of H3K27me3 prior to EWSR1::FLI1 activation. In this study, upon expression of EWSR1::FLI1 in human pediatric mesenchymal stem cells, considered the putative cell of origin of Ewing sarcoma, we unraveled the genome-wide redistribution of H3K27me3. Stemming from these results, we elucidated the contribution of the H3K27me3 demethylases KDM6A/UTX and KDM6B/JMJD3 in the transcriptional activity of EWSR1::FLI1-induced enhancers. KDM6A had a demethylase-independent role in recruiting BRG1 at EWSR1::FLI1-primed enhancers containing single GGAA motifs, which was critical for Ewing sarcoma tumor growth. Conversely, KDM6B demethylated H3K27me3 at specific EWSR1::FLI1-active enhancers, colocalizing with BRG1 at GGAA repeats. Loss of KDM6B impaired the growth of Ewing sarcoma tumor xenografts. These results highlight KDM6 demethylases as EWSR1::FLI1 functional partners with potential as targets for treating Ewing sarcoma., Our studies were supported by grants from AGAUR; the Spanish government through the Instituto de Salud Carlos III (PI16/00245 to J. Mora); the Ministry of Economy, Industry and Competitiveness (PID2022-142679NB-I00 to L. Di Croce); the Fundació La Caixa Health Research Grant (CI24-10473 to L. Di Croce); and Worldwide Cancer Research (2025_038 to L. Di Croce). We thank Dr. Marian Martínez-Balbás (Instituto de Biología Molecular de Barcelona, Consejo Superior de Investigaciones Científicas) for the critical reading of the manuscript. We also thank Dr. Mariona Suñol and Sandra Rincón (Hospital Sant Joan de Déu). We are grateful to the Band of Parents at Hospital Sant Joan de Déu for supporting the overall research activities of the Pediatric Cancer Group (Institut de Recerca Sant Joan de Déu and Pediatric Cancer Center Barcelona).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The interferon γ pathway enhances pluripotency and X-chromosome reactivation in iPSC reprogramming

  • Barrero Asencio, Mercedes
  • Lazarenkov, Aleksey
  • Blanco, Enrique
  • Palma, Luis G.
  • López Rubio, Anna V.
  • Bauer, Moritz, 1987-
  • Bigas Salvans, Anna
  • Di Croce, Luciano
  • Sardina, Jose Luis
  • Payer, Bernhard
Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) requires activation of the pluripotency network and resetting of the epigenome by erasing the epigenetic memory of the somatic state. In female mouse cells, a critical epigenetic reprogramming step is the reactivation of the inactive X chromosome. Despite its importance, a systematic understanding of the regulatory networks linking pluripotency and X-reactivation is missing. Here, we reveal important pathways for pluripotency acquisition and X-reactivation using a genome-wide CRISPR screen during neural precursor to iPSC reprogramming. In particular, we discover that activation of the interferon γ (IFNγ) pathway early during reprogramming accelerates pluripotency acquisition and X-reactivation. IFNγ stimulates STAT3 signaling and the pluripotency network and leads to enhanced TET-mediated DNA demethylation, which consequently boosts X-reactivation. We therefore gain a mechanistic understanding of the role of IFNγ in reprogramming and X-reactivation and provide a comprehensive resource of the molecular networks involved in these processes., This work was supported by Agencia Estatal de Investigación (AEI) of the Spanish Ministry of Science and Innovation (MCIN) and Fondo Europeo de Desarrollo Regional (FEDER) of the European Union grant BFU2017-88407-P (B.P.); AEI of MCIN grant EUR2019-103817/AEI/10.13039/501100011033 (B.P.); grant PID2021-123383NB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE (B.P.); AEI of MCIN grant PID2019-111243RA-I00 (J.L.S.); AEI of MCIN grant PID2022-142679NB-I00 (L.D.C.); AXA Research Fund (B.P.); Agencia de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) 2017 grant SGR 346 (B.P.); AGAUR 2021 grant SGR 01222 (B.P.); Instituto de Salud Carlos III grant CP19/00176 (J.L.S.); Worldwide Cancer Research 20-0269 (J.L.S.); Ramón Areces Foundation (Doctoral Thesis in Life Sciences Fellowship) (M. Barrero); and La Caixa International PhD Fellowship Program (M. Bauer).